Beyond the technical aspects, this distinction has strong clinical value since aPS/PT but not aPT-A are the ones often found in APS patients at high risk of thrombosis (3, 4), arguing for a potential pathogenic role in the onset and progression of APS disease. Here, F2 is linked to autoimmune polyendocrinopathy.